CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4 Shares withheld for taxes Chairman, CEO & President gave up 16,362 shares (to pay taxes)
- 4 Option exercise Exec. Vice Pres. HR acquired 3,000 shares (option exercise)
- 4 Shares withheld for taxes EVP, R&D, Chief Sci. Officer gave up 797 shares (to pay taxes)
- 4 Option exercise EVP-Technical Operations acquired 3,000 shares (option exercise)
- 4 Shares withheld for taxes EVP, R&D, Chief Sci Officer gave up 5,313 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 4,279 shares (option exercise)
- 4 Option exercise Director acquired 4,279 shares (option exercise)
- 4 Option exercise Director acquired 4,279 shares (option exercise)
- 4 Option exercise Director acquired 4,279 shares (option exercise)
- 4 Option exercise Director acquired 4,279 shares (option exercise)
- 4 Grant or award Director acquired 10,432 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 10,432 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, Technical Operations gave up 1,594 shares (to pay taxes)
- 4 Option exercise Exec. Vice Pres. HR acquired 4,500 shares (option exercise)
- 4 Shares withheld for taxes Exec VP Finance, CFO gave up 1,594 shares (to pay taxes)
- 4 Open-market sale Exec VP Finance, CFO sold 5,930 shares at $6.12 ($36,292)
Page 10 of 28 · 560 filings